Cyient DLM Other Announcement
US step-down subsidiary renamed from Altek Electronics Inc to Cyient DLM Electronics Inc for brand alignment. No change to ownership, operations, assets, or legal status.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
31 announcements with these filters
US step-down subsidiary renamed from Altek Electronics Inc to Cyient DLM Electronics Inc for brand alignment. No change to ownership, operations, assets, or legal status.
Cyient DLM has granted 1,80,000 stock units and 3,00,000 options to its associates under the RSU and ASOP 2023 schemes, respectively.
Cyient DLM Limited received a penalty of ₹4.11 Lakh from the Income Tax Department for the delayed filing of Form 61A.
Cyient DLM delivered its strongest Q1 with record order intake, though aggressive expansion into AI and Robotics introduces execution risk. Management is pivoting from pure EMS to higher-margin B2S products to boost profitability.
Cyient DLM reported Q1FY27 financial results, noting revenue growth of 34.3% YoY and its highest-ever order book since listing.
Q1 FY27 presentation highlighting 34.3% YoY revenue growth and margin expansion. Strategy focuses on high-reliability sectors like AI data centers and robotics.
Cyient DLM Ltd reported revenue from operations of ₹373.8 Cr (+34.3% YoY) and net profit of ₹16.3 Cr (+117.3% YoY) for Q1 FY27.
Mr. Yadama Muralidhar will cease to be a Non-Executive Independent Director of Cyient DLM Limited effective from the close of business hours on July 20, 2026.
Cyient DLM Ltd has filed its quarterly shareholding pattern for the period ended June 30, 2026. This document discloses the distribution of shareholding across promoter and public categories.
Cyient DLM Limited submitted its Regulation 74(5) certificate for the quarter ended 30 June 2026, confirming dematerialisation details to stock exchanges. The filing is for compliance record‑keeping.
Cyient DLM Ltd notified that its Board will meet on 21 July 2026 to consider Q1 FY27 unaudited results. The notice is filed with BSE.
Cyient DLM held its 33rd Annual General Meeting on June 30, 2026. The meeting covered financial statements, director appointments, and auditor remuneration.
Cyient DLM Limited has issued a notice for its 33rd Annual General Meeting scheduled for June 30, 2026. Key agenda items include financial statement adoption and director re-appointments.
Cyient DLM Limited has dispatched its Annual Report for FY 2025-26. The report includes the Business Responsibility and Sustainability Report and notice for the upcoming AGM.
Cyient DLM Limited allotted 18,972 equity shares following the exercise of stock options under its RSU plan 2023. This allotment reflects routine employee incentive plan execution.
Cyient DLM appointed Ramakanth Alapati as President & Chief Strategy and Growth Officer. Based in Dallas, he will lead strategic initiatives and global customer expansion.
Cyient DLM appointed Ramakanth Alapati as President and Chief Strategy and Growth Officer. The appointment is effective from May 18, 2026, strengthening the leadership team.
Cyient DLM Limited reported full utilization of its ₹663.15 Crore IPO proceeds as of March 2026. The funds were deployed for working capital, debt repayment, and acquisitions.
Cyient DLM Limited submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirms overall regulatory adherence with no non-compliances.
Cyient DLM Limited announced the resignation of Mr. Mujeeb Rahiman from his position as Vice President and Head of Operations - India. The resignation was effective from April 30, 2026. This change falls under senior management personnel cessation as per SEBI regulations.
Mr. Mujeeb Rahiman has resigned as Vice President & Head of Operations - India at Cyient DLM Limited. He will cease to be senior managerial personnel effective 30 April 2026. The company has informed exchanges of this leadership change as per regulatory requirements.
Cyient DLM reported Q4 FY26 revenue of ₹3,691M and EBITDA of ₹431M (11.7% margin). Management focuses on transitioning from a manufacturing partner to a value-adding strategic partner with a record order book.
Cyient DLM reported a revenue decline of 13.8% YoY for Q4, though margins remained healthy above 10%. Growth was hit by geopolitical delays and a high base effect, despite a record-high order book.
Cyient DLM reported its Q4 and FY26 results, achieving a record order book of ₹2,416.6 Crore. FY26 revenue stood at ₹1,261.5 Crore with a normalized EBITDA margin of 10.3%. The company added six new logos and recorded a strong book-to-bill ratio of 1.5, indicating robust future revenue visibility.
Cyient DLM reported FY26 revenue of ₹12,615 Mn with a shift towards its 'SET' strategy (Strengthen-Expand-Transform) focusing on Aerospace and Defense.
Cyient DLM Ltd reported its audited financial results for FY 2025-26. The Board also approved the reappointment of Mr. B.V.R Mohan Reddy as a Non-Executive Director and the appointment of M/s. G A and Associates as Cost Auditors. The company reported annual consolidated revenue from operations of ₹1,261.49 Crore and net profit of ₹73.28 Crore.
Cyient DLM Ltd reported its audited financial results for FY 2025-26. The Board also approved the reappointment of Mr. B.V.R Mohan Reddy as a Non-Executive Director and the appointment of M/s. G A and Associates as Cost Auditors. The company reported annual consolidated revenue from operations of ₹1,261.49 Crore and net profit of ₹73.28 Crore.
Cyient DLM Ltd reported net profit of ₹11.2 Cr (+1.8% YoY) for Q3 FY26.
Cyient DLM Limited submitted the compliance certificate under Regulation 74(5) of SEBI (DP) Regulations for the quarter ended March 31, 2026. The certificate, issued by KFin Technologies Limited, confirms the processing of dematerialization and rematerialization requests as required by regulatory standards.
Cyient DLM Ltd has scheduled a Board Meeting on April 21, 2026, to consider and approve the audited financial results for the quarter and year ended March 31, 2026. This is a routine regulatory intimation for investors regarding upcoming financial disclosures.